Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 217 clinical trials
featured
A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF

urinary tract cancer
  • 1062 views
  • 08 Dec, 2020
  • 62 locations
featured
A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Plus Pembrolizumab Versus Pemigatinib Alone Versus Standard of Care as First-Line Treatment for Metastatic or Unresectable Urothelial Carcinoma in Cisplatin-Ineligible Participants Whose Tumors Express FGFR3 Mutation or Rearrangement

urothelial carcinoma who are not eligible to receive cisplatin, are harboring FGFR3 mutation or rearrangement, and who have not received prior treatment.  

bladder carcinoma
urothelial carcinoma
metastatic urothelial carcinoma
bladder cancer
  • 22 views
  • 14 Dec, 2020
  • 64 locations
featured
Advanced Urothelial Carcinoma

People with advanced urothelial carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center.    

  • 13 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma (516-003)

This is a study involving an investigational (experimental) drug called sitravatinib, given in combination with the immunotherapy nivolumab (also known as OPDIVO®).  Sitravatinib is designed to block specific proteins that are thought to cause tumors to grow and to prevent growth of new blood vessels that help cancer tumors to …

advanced urothelial cancer
advanced urothelial carcinoma
carcinoma
nivolumab
urothelial carcinoma
  • 80 views
  • 23 Dec, 2020
  • 1 location
featured
Metastatic Urothelial Cancer

People with metastatic urothelial cancer are asked to participate in a research study being conducted by Northwell Health/Monter Cancer Center.  

  • 4 views
  • 02 Aug, 2019
  • 1 location
featured
CALGB 90601: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

CALGB 90601: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

  • 176 views
  • 08 Nov, 2020
  • 1 location
Prognostic Value of Lymph Node Dissection in Patients With Transitional Cell Carcinoma of the Upper Urinary Tract

Recent studies showed the therapeutic benefit of lymphadenectomy in advanced stage urothelial carcinoma of the upper urinary tract, but there is still a lack of prospective studies. Thus, the

  • 0 views
  • 08 Nov, 2020
  • 1 location
Paclitaxel and TAK-228 in Urothelial Carcinoma

Phase II Multicentre, single arm, open label study of Paclitaxel and TAK-228 in metastatic urothelial carcinoma (UC) and the impact of PI3K-mTOR pathway genomic alterations

  • 1 views
  • 08 Nov, 2020
  • 3 locations
Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma

. This study will recruit patients with pathologically and radiographically confirmed metastatic bladder urothelial carcinoma that the efficacy is evaluated as partial response (PR) or

carcinoma
metastasis
gemcitabine
transitional cell carcinoma of bladder
cancer treatment
  • 29 views
  • 08 Nov, 2020
  • 1 location
A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma

evaluate the combination of Pembrolizumab + sEphB4-HSA in the population of patients with previously untreated advanced (metastatic or recurrent) urothelial carcinoma who are chemotherapy ineligible or who

  • 5 views
  • 30 Aug, 2020
  • 1 location